Neuroprotection and Neurogenesis in Brain Repair, Center for Neurosciences and Cell Biology of Coimbra, Faculty of Medicine, University of Coimbra, 3004-504 Coimbra, Portugal.
Cell Mol Neurobiol. 2011 Aug;31(6):835-46. doi: 10.1007/s10571-011-9673-6. Epub 2011 Mar 17.
Degeneration of neural retina causes vision impairment and can lead to blindness. Neural stem and progenitor cells might be used as a tool directed to regenerative medicine of the retina. Here, we describe a novel platform for cell phenotype-specific drug discovery and screening of proneurogenic factors, able to boost differentiation of neural retinal progenitor cells. By using single cell calcium imaging (SCCI) and a rational-based stimulation protocol, a diversity of cells emerging from differentiated retinal neurosphere cultures were identified. Exposure of retinal progenitor cultures to KCl or to α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) stimulated Ca(2+) transients in microtubule-associated protein 2 (MAP-2) positive neurons. Doublecortin (DCX) and polysialated neural cell adhesion molecule (PSA-NCAM) positive neuroblasts were distinguished from differentiated neurons on the basis of their response to muscimol. Ca(2+) fluxes in glial fibrillary acidic protein (GFAP) or glutamine synthetase (GS) positive cells were induced by ATP. To validate the platform, neurospheres were treated with brain-derived neurotrophic factor (BDNF) (proneurogenic) or ciliary neurotrophic factor (CNTF) (gliogenic factor). BDNF increased the percentage of differentiated cells expressing Tuj-1 sensitive to KCl or AMPA and reduced the population of cells responding to muscimol. CNTF exposure resulted in a higher number of cells expressing GFAP responding to ATP. All together, our data may open new perspectives for cell type-specific discovery of drug targets and screening of novel proneurogenic factors to boost differentiation of neural retina cells to treat degenerative retinal diseases.
神经视网膜的变性导致视力障碍,并可能导致失明。神经干细胞和祖细胞可作为一种工具,用于视网膜的再生医学。在这里,我们描述了一种用于细胞表型特异性药物发现和神经前体细胞筛选的新平台,该平台能够促进神经视网膜祖细胞的分化。通过使用单细胞钙成像(SCCI)和基于理性的刺激方案,从分化的神经球培养物中鉴定出多种细胞。将视网膜祖细胞培养物暴露于 KCl 或α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)刺激微管相关蛋白 2(MAP-2)阳性神经元中的 Ca(2+)瞬变。基于其对 muscimol 的反应,将双皮质素(DCX)和多涎酸神经细胞粘附分子(PSA-NCAM)阳性神经母细胞与分化神经元区分开来。胶质纤维酸性蛋白(GFAP)或谷氨酰胺合成酶(GS)阳性细胞中的 Ca(2+)通量由 ATP 诱导。为了验证该平台,用脑源性神经营养因子(BDNF)(神经前体细胞)或睫状神经营养因子(CNTF)(神经胶质细胞因子)处理神经球。BDNF 增加了对 KCl 或 AMPA 敏感的分化细胞中表达 Tuj-1 的细胞的百分比,并减少了对 muscimol 有反应的细胞群体。CNTF 暴露导致表达 GFAP 的细胞数量增加,对 ATP 有反应。总的来说,我们的数据可能为细胞类型特异性药物靶点发现和筛选新的神经前体细胞开辟新的前景,以促进神经视网膜细胞的分化,从而治疗退行性视网膜疾病。